Medindia

X

Frost & Sullivan to Present the 2009 Healthcare Innovation Awards

Wednesday, November 18, 2009 General News J E 4
Advertisement


MOUNTAIN VIEW, Calif., Nov. 17 Frost & Sullivan, the Growth Partnership Company, is pleased to announce that the consulting firm will be naming the recipients of its 2009 Healthcare Innovation Awards. The Awards will be announced during a banquet that will take place on Thursday, November 19, 2009 in San Antonio, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

The Healthcare Innovation Awards are given to companies that have made a significant contribution to the delivery and management of healthcare. Such companies have shown success at meeting the needs of patients and other stakeholders in the healthcare industry by pioneering products, practices, technology, and ideas.

The banquet will take place from 5:00 p.m. until 10:00 p.m. on Thursday, November 19, 2009 at The Westin La Cantera, located at 16641 La Cantera Parkway, San Antonio, TX, 78256. For more information, please contact Jake Wengroff at 210.247.3806 or jake.wengroff@frost.com.

Frost & Sullivan will recognize companies, products, processes, and executives that have achieved world-class performance within their segment of the healthcare industry. Throughout the evening, Frost & Sullivan will honor Award recipients for demonstrating excellence and innovation in such areas as cardiovascular devices, medical imaging informatics, personalized medicine, neurology, and oncology, among other areas.

Ann McCaughan, Chief Operating Officer and Chief Technology Officer of Noninvasive Medical Technologies, will be receiving the 2009 North American Lifetime Achievement Award for Remote Patient Monitoring. Widely acknowledged as one of the leading experts in cardiac home care, Ann McCaughan's pioneering vision and efforts in the industry have led to a number of commercially successful and novel healthcare monitoring products.

Public relations and marketing firm Padilla Speer Beardsley will be sponsoring the event.

To choose Award recipients, Frost & Sullivan's healthcare analyst team tracks emerging and existing markets and evaluates the contributions of industry participants. Analysts quantify several market factors for each participant according to predetermined criteria that define innovation in healthcare. The analysts also consider the pace of technology development and deployment, and the potential relevance or significance of the innovation to the overall industry. The Award recipient is ultimately chosen after a thorough evaluation of this research.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.awards.frost.com.

Contact: Jake Wengroff 210.247.3806 jake.wengroff@frost.com

SOURCE Frost & Sullivan
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Linkwell Corporation Reports on Operating Results ...
S
YM BIOSCIENCES REPORTS CYT997 ORAL VASCULAR DISRUP...